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Abstract. Often there is a need to introduce classification costs into the 
classifier for predicting disease.  This is determined by the type of disease, its 
associated classification cost matrix and/or the target population on which the 
classifier will be used.  Diabetes has higher costs associated with false 
negatives than true positives, as the disease can progress very rapidly when left 
untreated.  There are two ways to skew a classifier to work towards the given 
classification cost matrix: (1) by changing the classification probability value, 
P* based on the classification cost matrix or (2) by rebalancing the training set 
to introduce more negative cases.  Using a diabetes data set, this paper 
compares the two methods.    The results indicate comparable values of 
predictive accuracy and expected classification costs for either method.  
However, P* works better when the p-value is less than 0.2.  Hence for diabetes 
classification matrices, the P* method is recommended.  
Keywords: Classification, cost-sensitive learning, rebalancing. 
1   Introduction 
The Pima Native American diabetes dataset was collected by the National Institute of 
Diabetes and Digestive and Kidney Diseases and was donated for public use by 
Sigillito [1].  The data reports the diabetic status (diabetic or non-diabetic) of 768 
women, along with data for 8 health-status variables.  The population lives near 
Phoenix, Arizona, USA.  The database has 768 cases (500 no disease, 268 disease).  
The data does not include classification costs.  The diagnostic, binary-valued variable 
investigated is whether the patient shows signs of diabetes according to World Health 
Organization criteria (i.e., if the 2 hour post-load plasma glucose was at least 200 
mg/dl at any survey examination or if found during routine medical care.    
Several studies have used the Pima Native American diabetes dataset to test the 
validity of various classifiers.  [2] used the Pima diabetes data to test the performance 
of a Generalized Partial Least Square classifier that they developed in comparison to 
six other commonly used classification algorithms.  [3] developed a Bayesian logistic 
regression model and reported modest success when they tested it on the Pima data.  
Their results supported the use of the complete set of variables in the Pima data as 
well as a subset of the variables that produced similar error rates.  [4] used the Pima 
data to compare their large margin nearest neighbor algorithm (LAMANNA) to yet 
another set of popular algorithms. 
All of the above studies reported significant success differentiating diabetic and 
non-diabetic subjects in the Pima database.  Indeed, when classification costs are 
symmetric (that is, when the costs of a false negative classification is roughly 
equivalent to the cost of a false-positive classification), accuracy, sensitivity, and 
specificity are appropriate measures of success. 
2   Asymmetric Classification Costs for Diabetes 
Classification costs are defined as the cost of correctly or incorrectly predicting a case 
as positive or negative.  Given a specification of costs for correct or incorrect 
predictions, a case should be predicted based on the lowest expected cost [5].  
Asymmetric classification cost matrices arise when the cost of true positive, false 
positive, true negative and false negative are different.  These situations are common 
in certain domains, such as medical diagnostics.  The resulting classification cost 
matrices are often asymmetric.  In the instance of diabetes, for instance, a patient who 
is wrongly told that they are non-diabetic may go un-treated for years and incur 
irreversible cardio-vascular damage.  Ultimately, the financial and quality of life costs 
of a false-negative diagnosis may prove exponentially greater than the costs of an 
erroneous false-positive.  Hence in diabetes detection, the classifications costs for a 
false negative may be much higher than for a false positive, when all types of “costs” 
are considered [6].  [7] demonstrated and compared several cost-sensitive algorithms 
across various data-sets (including the Pima diabetes data-set.)  The boosting 
procedures analyzed by Ting were based on the well known tree-learning algorithm 
C4.5 [8].  This study uses a regression-based method to examine the performance of 
Elkan’s [5] rebalancing algorithm. 
Moreover, the occurrence rate of diabetes varies greatly across different ethnicity 
and races.  If a classifier for diabetes prediction is built from a sample of 
predominantly Anglo origin, to utilize that classifier on Asian subjects, classification 
costs need to be introduced to bias the classifier for the higher prevalence rates of 
diabetes seen in the Asian population.  
2.1   Example Diabetes Costs Matrices  
It is possible that for certain conditions, such as for high risk groups such as Asian 
populations or Native Indian population, it is better to have a false positive diagnosis 
than a true negative. Evidence suggests that some early treatment can improve 
physician performance, cost-effectiveness and patient outcomes [9].  This is because 
diabetes tends to be a silent disease for an extended period of time.  Hence, even 
before full blown diabetes is developed and diagnosed, a patient in the high risk 
domain may have severe consequences.  Hence for that domain, the cost of a false 
positive may be lower than a true negative. 
Reasonable diabetes classification cost matrices may involve the ratio of the cost of 
a false negative over the cost of a false positive set at 4 times, 9 times or 16 times, etc.  
The detection of diabetes also involves treatment costs and hence the ration of the 
cost of a true positive over the cost of a true negative can be 2, 3, 4 , etc.  Table 1 
shows some p* values generated from reasonable cost asymmetric cost matrices [10]. 
 
Table 1: p* values for Example Asymmetric Cost Matrices for Diabetes. 
 
Cost of TN Cost of FP Cost of TP Cost of FN p* Value 
1 2 4 8 0.2 
1 3 9 27 0.1 
1 4 16 64 0.058824 
1 2 10 20 0.090909 
1 2 10 30 0.047619 
1 2 10 40 0.032258 
1 2 10 50 0.02439 
1 2 10 60 0.019608 
1 2 20 60 0.02439 
1 2 10 70 0.016393 
 
Regardless of the actual scenarios, it may be noted that the p* value for typical 
diabetes classification cost matrices have very low p* values, between 0.016 to 0.20.   
Hence it is important to identify the optimal approach – whether P*  or rebalance to 
introduce classification costs into a diabetes classifier. 
3   Methods of Introducing Classification Costs 
The two ways to bias the classifier to account for the asymmetric classification cost 
matrices are (Elkan, 2001): 
1. Changing the classification probability value, P* based on the classification 
cost matrix.  The classifier can be biased by using a different probability 
value, p*, which is calculated from the specified classification cost matrix 
using the formula (Elkan, 2001): 
p*  =  (CFP – CTN) / (CFP – CTN + CFN – CTP ) . (1) 
 
Where, CTP is the cost of correctly classifying a case as positive and CTN is 
the cost of correctly classifying a case as negative, CFP is the cost of 
incorrectly classifying a case as positive and CFN is the cost of incorrectly 
classifying a case as negative. 
2. Rebalancing the training set to adjust the negative cases to bias the classifier 
to work towards the target p-value based on the asymmetric classification 
cost matrix.  The formula to make a target probability, P*, the number of 
negative cases in the training set needs to be multiplied by (Elkan, 2001):  
 
Number of negative cases = P* (1 - P0) / (1 - P*) (P0) . (2) 
 
Where, P0 is the probability threshold for the cost unaware classifier. 
4   Research Goals 
The goals of this research paper are as follows: 
1. Evaluate the impact of introducing bias into the logistic regression 
classification algorithm by changing the p-value, henceforth, to be referred 
to as the P*-method and by rebalancing the sample.  The specific measures 
to assess classification performance will be accuracy, specificity and 
sensitivity. 
2. Understand whether one of the above methods will work better with the type 
of data being used – i.e., the diabetes data set. 
3. Develop some understanding on the nature of diabetes data and the specific 
characteristics of the classification cost matrices that are prevalent in the 
domain of diabetes classification. 
5   Research Hypotheses 
When symmetric cost matrices are used an unbiased classifier is generated with a p-
value of 0.5, without regard to the classification cost matrix.  An unbiased classifier 
assumes the cost of a false positive is equal to the cost of a false negative and the cost 
of a true positive is equal to the cost of a true positive.  This may not reflect the real 
world for scenarios such as classification of diabetes, where the classification costs 
are not equal. A biased classifier is developed by giving consideration to the 
classification cost matrix, hence the expected classification costs produced by the 
biased classifier (generated either by p* or rebalance methods) will be different from 
the unbiased classifier. 
 
Hypothesis 1 - The mean of the expected classification costs for the unbiased 
classifier will be significantly different than the expected classification costs 
for the biased classifiers based on p* or rebalancing. 
 
Elkan (2001) contends that there is no significant difference in classification 
performance in terms of predictive accuracy and expected classification cost whether 
bias is introduced in the classifier by the P* or the rebalance methods given the same 
classification cost matrix. 
 
Hypothesis 2 – The mean of the predictive accuracy for the biased classifiers 
using the p* method and the rebalance methods will not be significantly 
different for different classification cost matrices. 
 
Hypothesis 3 - The mean of the expected classification costs for the biased 
classifier using p* will not be significantly different from the mean of the 
expected classification costs for the biased classifier using rebalancing. 
 
As the p-value corresponding to the asymmetric classification cost matrix 
approaches the value of 0.2 or lower, the corresponding rebalancing ratio for negative 
cases becomes smaller and smaller.  The result is that the number of negative cases in 
the training sample may become extremely small.  Similarly, on the other extreme, as 
the p-value corresponding to the asymmetric classification cost matrix approaches the 
value of 0.8 or higher, the corresponding rebalancing ratio for negative cases becomes 
larger and larger.  The result is that the number of positive cases in the training 
sample may become extremely small.  In either of these two scenarios, the biased 
classifier will over learn the small number of cases and the end result will be poorer 
predictive accuracy for the biased classifier produced through rebalance over the one 
that produced through the p* method. 
 
Proposition 1 - The performance of the biased classifier using p* will be 
better than the biased classifier using rebalancing, when the p-value, 
corresponding to the asymmetric classification cost matrix is <= 0.2 or >= 
0.8. 
6   Research Methodology 
The methodology consists of comparing the performance of using the P* formula and 
the rebalancing formula from Elkan (2001) to introduce bias into the diabetes 
classifier to map different types of classification costs matrices.  The cost matrices are 
developed to match the p* values listed in Table 1. 
Experimental design will consist of the use of paired T-tests to compare the values 
of the performance measures across the two methods used to introduce classification 
cost bias – p* and rebalance.  To establish statistical power for the experiment a total 
of 19 trials will be conducted evenly spread across the range of p* values (.05 to .95).  
The performance measures that will be compared include accuracy, specificity and 
sensitivity measures and expected classification costs. 
6.1   Pima Diabetes Dataset 
The data set consisted of 768 cases (500 with no disease and 268 with disease) with 
the following variables for each case: 
 
1. Number of times pregnant 
2. Plasma glucose concentration a 2 hours in an oral glucose tolerance test 
3. Diastolic blood pressure (mm Hg) 
4. Triceps skin fold thickness (mm) 
5. 2-Hour serum insulin (mu U/ml) 
6. Body mass index (weight in kg/(height in m)^2) 
7. Diabetes pedigree function 
8. Age (years) 
6.2   Experimental Steps 
The following steps were performed.  All logistic regressions were run using 20 fold 
re-sampling to improve algorithm accuracy and performance. 
 
1. Cleaning the data to remove cases that have invalid values.   This includes 
taking out the cases that have BMI (Body Mass Index) or glucose values of 0 
and/or Blood Pressure of 0-10.  There were 724 cases (475 with no disease 
and 249 with disease) in the final data set after cleanup. 
2. The unbiased classifier was produced using a training/test split of 469 (301 
with no disease and 168 with disease) in the training set and 255 (174 with 
no disease and 81 with disease) in the test set using Logistic Regression to 
classify the data without introducing any bias using a p value of 0.5.  The 
accuracy, specificity and sensitivity measures for the classification were 
obtained from SPSS.   The expected classification cost using a representative 
classification cost matrix was also obtained 
3. The logistic regression was rerun with different P values from .05 to .95 at 
.05 intervals. The accuracy, specificity and sensitivity measures for the 
classification were obtained from SPSS.  The expected classification cost for 
each run using a representative classification cost matrix was obtained. 
4. The rebalance multiplier was calculated given a value of p* based on the 
classification cost matrix.  The multiplier was used to adjust the negative 
training cases.  SPSS was used to find a given number of random negative 
cases from the 301 negative cases in the training set. 
5. Hypothesis testing was done using t-tests at alpha levels of .95 to check for 
significant differences in the means of the accuracy, sensitivity, specificity 
and  expected classification costs from the rebalance method to the P* 
methods. 
7   Results 
The unbiased classifier for p=0.5 using the data set was generated using Logistic 
Regression and the Enter Method.  The results with all the variables indicated that 
Blood Pressure, skinfold, times pregnant and insulin were not significant.  The data 
was cleaned and a subsequent logistic regression was run without skinfold, insulin1  
and blood pressure (see table 2).   
The final regression coefficients and the classification results of the unbiased 
classifier are shown in Figure 1. 
 
Table 2. Variable(s) entered on step 1: timesPreg, BMI, Pedigree, Age, PlsGlucose. 
 
  B S.E. Wald df Sig. Exp(B) 
Step 1(a) timesPreg 
.096 .047 4.192 1 .041 1.101 
  BMI 
.085 .018 23.334 1 .000 1.088 
  Pedigree 
.930 .355 6.851 1 .009 2.535 
  Age 
.011 .011 1.083 1 .298 1.011 
  PlsGlucose 
.031 .004 52.167 1 .000 1.031 
  Constant 
-8.370 .863 94.134 1 .000 .000 
 
 
 
 Classification Table(c) 
 
  Observed Predicted 
Selected Cases(a) Unselected Cases(b) 
CLASS CLASS 
0 1 
Percentage 
Correct 0 1 
Percentage 
Correct 
CLASS 0 264 37 87.7 161 13 92.5 
1 78 90 53.6 32 49 60.5 
Step 1 
Overall Percentage 
    75.5     82.4 
 
 
Figure 1. The unbiased Logistic Regression Model and classification results from SPSS 
7.1   Results of Biased Classifier Using p* 
The classification results for the biased classifier generated using the P* method for 
different p-value cases corresponding to different classification cost matrices are 
shown in Table 3. 
7.2   Results of Biased Classifier Using Rebalance 
The classification results for the biased classifier generated using the Rebalance 
method for different p-value cases corresponding to different classification cost 
matrices are shown in Table 4. 
 
 
                                                        
1
 There was high correlation between glucose and insulin variables in the data set.  This created 
ambiguity in the regression model when both were included in the model.  Hence the insulin 
variable was dropped from the regression models. 
 Table 3. Classification Results of the biased classifier using the p* Method  for 
different p-values. 
 
P-Value Classification Results Classification Algorithm Performance Measures 
P* TP FP TN FN Accuracy Specificity Sensitivity Classification 
costs 
0.95 2 1 173 79 0.68627 0.99425 0.02469 844.9 
0.90 3 1 173 78 0.6902 0.99425 0.03704 844.7 
0.85 12 1 173 69 0.72549 0.99425 0.14815 842.84 
0.80 15 2 172 66 0.73333 0.98851 0.18519 840.25 
0.75 20 5 169 61 0.74118 0.97126 0.24691 834.4 
0.70 27 5 169 54 0.76863 0.97126 0.33333 829.66 
0.65 32 5 169 49 0.78824 0.97126 0.39506 823.4 
0.60 35 7 167 46 0.79216 0.95977 0.4321 815.2 
0.55 40 11 163 41 0.79608 0.93678 0.49383 801.8 
0.50 49 13 161 32 0.82353 0.92529 0.60494 784 
0.45 56 17 157 25 0.83529 0.9023 0.69136 761.8 
0.40 59 24 150 22 0.81961 0.86207 0.7284 732.32 
0.35 62 30 144 19 0.80784 0.82759 0.76543 703.16 
0.30 66 43 131 15 0.77255 0.75287 0.81481 651.2 
0.25 74 60 114 7 0.73725 0.65517 0.91358 567 
0.20 78 73 101 3 0.70196 0.58046 0.96296 553.6 
0.15 79 102 72 2 0.59216 0.41379 0.97531 558 
0.10 80 140 34 1 0.44706 0.1954 0.98765 564 
0.05 81 166 8 0 0.34902 0.04598 1 569.8 
0.01 81 174 0 0 0.31765 0 1 603 
 
7.3   Hypothesis Testing 
A T-test was done on the classification cost measures obtained from the 18 classifiers 
using different p* values to check if there is a significant difference between the mean 
classification cost of the biased classifiers obtained using p* methods and with the 
classification cost of the unbiased classifier (784).  The results of the T-test shows 
significant difference (t = -2.218, p = .040) in the mean classification cost for the 
biased classifiers at the 95% confidence level (t a=.05, df=18 = 1.96).   
A T-test was also done on the classification cost measures obtained from the 18 
classifiers using rebalanced training set samples to check if there is a significant 
difference between the mean classification cost of the biased classifiers obtained 
using the rebalance method and with the classification cost of the unbiased classifier 
(784).  The results of the T-test shows significant difference (t = -2.264, p = .035) in 
the mean classification cost for the biased classifiers at the 95% confidence level       
(t a=.05, df=18 = 1.96 ). 
  
Table 4. Classification Results of the biased classifier using the Rebalance Method 
for different p-values 
 
Rebalance Parameters Classification 
Results 
Classification Algorithm Performance 
Measures 
Positive 
cases 
Negative 
cases 
Rebalance 
multiplier 
TP FP TN FN Acc Specificity Sensitivity Class 
Costs 
168 5719 nX19 0 0 174 81 0.682 1.000 0.000 846 
168 2709 nX9 3 1 173 78 0.690 0.994 0.037 844.7 
168 1703 nX5.6 10 1 173 71 0.718 0.994 0.123 843.2 
168 1204 nX4 14 1 173 67 0.733 0.994 0.173 841.5 
168 1204 nX4 14 1 173 67 0.733 0.994 0.173 834.73 
168 903 nX3 19 5 169 62 0.737 0.971 0.235 829.66 
168 702 nX2.3 27 5 169 54 0.769 0.971 0.333 823.4 
168 559 nX1.8 32 5 169 49 0.788 0.971 0.395 812.84 
168 452 nX1.5 37 8 166 44 0.796 0.954 0.457 797.48 
168 368 nX1.2 44 12 162 37 0.808 0.931 0.543 770 
168 246 nX0.8 57 19 155 24 0.831 0.891 0.704 751.4 
168 201 nX0.6 58 25 149 23 0.812 0.856 0.716 717.24 
168 162 nx0.5 63 33 141 18 0.800 0.810 0.778 679.06 
168 129 nX0.4 67 45 129 14 0.769 0.741 0.827 622.7 
168 100 nX0.3 71 60 114 10 0.725 0.655 0.877 541.7 
168 75 nX0.2 78 74 100 3 0.698 0.575 0.963 540 
168 53 nX0.1 78 90 84 3 0.635 0.483 0.963 555.5 
168 33 nX0.1 79 107 67 2 0.573 0.385 0.975 592.7 
168 16 nX0.05 80 133 41 1 0.475 0.236 0.988 672 
168 3 nX0.01 80 140 34 1 0.447 0.195 0.988 607 
 
This supports Hypothesis 1 that the expected classification costs of the biased 
classifiers obtained using the either the p* or the rebalance methods will be 
significantly different from the classification costs obtained from the unbiased 
classifier. 
7.4   Testing Hypothesis 2 
A Paired Samples T-test was done on the accuracy measures of the 36 biased 
classifiers obtained from the p* method and the rebalance method (18 from each of 
the methods).  The results of the T-test shows no significant difference (t = -1.386, 
p=.183) in the mean scores for the predictive accuracy of the biased classifiers from 
the p* method and the rebalance methods at the 95% confidence level                         
(t a=.05, df=18 = 1.96). 
This supports the hypothesis 2 that the predictive accuracy of the biased classifiers 
obtained using p* method and the rebalance method will not be significantly different. 
7.5   Testing Hypothesis 3 
A Paired Samples T-test was done on the classification costs of the 36 biased 
classifiers obtained from the p* method and the rebalance method (18 from each of 
the methods).    The results of the T-test shows no difference (t = -597, p = .558) in 
the mean scores for the classifications costs of the biased classifiers from the p* 
method and the rebalance methods at the 95% confidence level (t a=.05, df=18 = 1.96). 
This supports the hypothesis that the expected classification costs of the biased 
classifiers obtained using p* method and the rebalance method will not be 
significantly different. 
7.6   Support for Proposition 1 
When P* is very low (less than 0.20) the number of negative training cases in the 
rebalancing method became very low.  Hence, the biased classifier obtained with the 
rebalance method tended to over-learn the given examples and performed relatively 
poorly as measured by accuracy on the test data set (when compared to the P* 
method). 
Likewise, when P* was very large (greater than 0.80) the number of positive 
training cases in the rebalancing method became very low.  Hence, the biased 
classifier obtained with the rebalance method tended to over-learn the given examples 
and performed relatively poorly as measured by accuracy on the test data set (when 
compared to the P* method). 
8   Discussion of Results 
The experimental results indicate support for all of the hypotheses in the study.  
Therefore, Elkan (2001)’s theorems are supported by our data and experiments.  The 
results of obtaining a biased classifier either by using the P* value or the rebalance 
method (using the formula in Elkan’s paper) is the same in terms of predictive 
accuracy of the classifier and the expected classification costs of the classifier 
(Hypotheses 2 and 3).   
As expected and predicted, the accuracy and classifications costs do differ for the 
unbiased classifier and the biased classifier, whether the biased classifier is obtained 
using the p* method or the rebalance method.  As the P* value was increased beyond 
0.5, the sensitivity went down while specificity went up.  Conversely, as P* was 
lowered below 0.5, sensitivity increased while specificity decreased (Hypothesis 1). 
Our results indicate that in the case of diabetes detection, classification cost 
matrices need to be skewed so that detection is emphasized.  False negatives are 
almost universally much more expensive than false positives.  Clearly, if a person is 
classified as a false negative and that person is truly diabetic, then the person’s health 
could significantly deteriorate and ultimately treating the patient will be a lot more 
expensive.  Hence for diabetes data and classification algorithms to detect diabetes – 
p* values of under 0.2 are appropriate. 
It was observed that the P* method works better than the rebalance method as the 
p-value become smaller and smaller- close to 0.20 and lower.  This is because the 
number of negative examples in the training set used by the rebalancing method 
becomes extremely low as the p* value is lowered. As a result, the classifier tends to 
over learn and its performance becomes extremely poor  (Proposition 1). 
9   Contributions 
The following findings are the significant contributions from this research:  
• Classification cost structures for Diabetes detection are skewed, as the cost 
of a false negative is much higher than a false positive. 
• The variables PlasmaGlucose and Insulin cannot be used together in a 
Logistic Regression model as they are highly correlated. 
• The valid p* values for diabetes detection data fall in the range of under 0.2. 
• The results of using the p* method or rebalance method by adjusting the 
number of negative training cases gives similar results in terms of accuracy 
and expected classification costs for the same classification cost matrix.   
• Due to the low p* values for the classification cost matrix for diabetes, the 
rebalancing method should not be used in the diabetes detection 
classification scenarios as the number of negative training cases becomes 
very low resulting in over-learning. 
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